Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
161.76
137.99
114.21
103.02
100.63
80.39
102.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
161.76
137.99
114.21
103.02
100.63
80.39
102.44
Raw Material Cost
46.09
29.38
20.94
23.10
28.08
19.52
25.03
Purchase of Finished goods
11.00
27.55
29.06
22.13
22.00
16.63
15.02
(Increase) / Decrease In Stocks
-0.01
4.43
7.46
-4.53
-2.16
-1.53
5.34
Employee Cost
29.63
21.65
14.63
19.01
14.70
12.03
18.25
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
25.54
20.82
22.68
17.62
14.74
12.42
16.41
Total Expenditure (Excl Depreciation)
112.25
103.83
94.77
77.33
77.36
59.07
80.05
Operating Profit (PBDIT) excl Other Income
49.51
34.16
19.44
25.69
23.27
21.32
22.39
Other Income
5.41
3.36
11.77
5.16
1.86
0.48
1.96
Operating Profit (PBDIT)
54.92
37.52
31.21
30.85
25.13
21.80
24.35
Interest
6.19
5.04
5.30
6.16
5.27
4.82
3.03
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
48.73
32.48
25.91
24.69
19.86
16.98
21.32
Depreciation
8.09
5.99
5.23
4.20
3.89
3.52
3.71
Profit Before Tax
40.64
26.49
20.68
20.49
15.97
13.46
17.61
Tax
10.52
5.31
2.71
4.06
2.90
2.55
3.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.12
21.18
17.97
16.43
13.07
10.91
14.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.12
21.18
17.97
16.43
13.07
10.91
14.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.26
1.45
0.14
-0.75
0.23
0.18
-1.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32.38
19.73
17.83
17.18
12.84
10.73
15.94
Equity Capital
46.05
46.05
46.05
46.05
46.05
33.27
30.51
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.03
4.28
3.87
3.73
2.79
3.23
5.22
Diluted Earnings per share
6.54
4.6
3.81
5.04
3.92
3.39
8.03
Operating Profit Margin (Excl OI)
32.28%
26.22%
18.54%
24.94%
23.68%
26.82%
21.86%
Gross Profit Margin
31.77%
24.93%
24.71%
23.97%
20.21%
21.36%
20.81%
PAT Margin
19.64%
16.25%
17.14%
15.95%
13.3%
13.72%
13.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 35.05% vs 30.61% in Jun 2025
Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 138.15% vs 34.33% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 231.03% vs 57.66% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -10.23% vs -25.11% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Senores Pharma. With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
161.76
0
161.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
161.76
0
161.76
Raw Material Cost
46.09
0
46.09
Purchase of Finished goods
11.00
0
11.00
(Increase) / Decrease In Stocks
-0.01
0
-0.01
Employee Cost
29.63
0
29.63
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
25.54
0.00
25.54
Total Expenditure (Excl Depreciation)
112.25
0
112.25
Operating Profit (PBDIT) excl Other Income
49.51
0.00
49.51
Other Income
5.41
0
5.41
Operating Profit (PBDIT)
54.92
0
54.92
Interest
6.19
0
6.19
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
48.73
0
48.73
Depreciation
8.09
0
8.09
Profit Before Tax
40.64
0
40.64
Tax
10.52
0
10.52
Provisions and contingencies
0.00
0
0.00
Profit After Tax
30.12
0
30.12
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
30.12
0
30.12
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-2.26
0
-2.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.38
0
32.38
Equity Capital
46.05
0
46.05
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
7.03
0
7.03
Diluted Earnings per share
6.54
0
6.54
Operating Profit Margin (Excl OI)
32.28%
0%
0.00
32.28%
Gross Profit Margin
31.77%
0%
0.00
31.77%
PAT Margin
19.64%
0%
0.00
19.64%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 20.92 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 35.05% vs 30.61% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 117.24%
Quarterly - Standalone Net Profit
Standalone Net Profit 6.43 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 138.15% vs 34.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 2,043.33%
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.52 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 231.03% vs 57.66% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 213.43%
Quarterly - Interest
Interest 1.58 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is -10.23% vs -25.11% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 132.35%
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.27%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
